stella
beta
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases — Stella
Recruiting
Back to Recurrent or Refractory Systemic Lupus Erythematosus trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov